Home » Stocks » NanoVibronix

NanoVibronix, Inc. (NAOV)

Stock Price: $1.46 USD -0.06 (-3.95%)
Updated Jul 31, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 8.80M
Revenue (ttm) 565,000
Net Income (ttm) -4.04M
Shares Out 4.61M
EPS (ttm) -0.57
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 31, 2020
Last Price $1.46
Previous Close $1.52
Change ($) -0.06
Change (%) -3.95%
Day's Open 1.51
Day's Range 1.46 - 1.54
Day's Volume 38,881
52-Week Range 1.32 - 3.50

More Stats

Market Cap 8.80M
Enterprise Value 8.36M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 4.61M
Float 3.44M
EPS (basic) -0.58
EPS (diluted) -0.57
FCF / Share -0.53
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 7,363
Short Ratio 0.09
Short % of Float 0.72%
Beta 0.07
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 15.58
PB Ratio 14.20
Revenue 565,000
Operating Income -3.84M
Net Income -4.04M
Free Cash Flow -3.83M
Net Cash 443,000
Net Cash / Share 0.07
Gross Margin 49.73%
Operating Margin -678.76%
Profit Margin -714.30%
FCF Margin -678.23%
ROA -247.36%
ROE -27,834.48%
ROIC -2,070.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$10.50*
Low
10.5
Current: $1.46
High
10.5
Target: 10.50
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013
Revenue0.530.320.240.230.150.200.21
Revenue Growth66.67%33.05%4.37%55.78%-27.59%-3.79%-
Gross Profit0.280.160.150.140.100.110.12
Operating Income-5.15-4.30-3.09-2.32-1.42-1.21-1.11
Net Income-5.79-4.15-4.97-2.83-2.88-2.65-1.99
Shares Outstanding6.946.454.964.583.540.160.16
Earnings Per Share-0.83-0.64-1.17-0.62-0.82-17.08-12.83
Operating Cash Flow-3.87-3.55-2.18-1.53-1.48-0.90-0.60
Capital Expenditures--0.01--0.01---0.01
Free Cash Flow-3.87-3.56-2.18-1.54-1.48-0.90-0.61
Cash & Equivalents1.340.904.360.111.610.090.09
Total Debt-----4.623.11
Net Cash / Debt1.340.904.360.111.61-4.53-3.01
Assets2.041.584.870.491.980.720.69
Liabilities0.691.121.232.992.196.343.99
Book Value1.350.463.63-2.50-0.21-5.62-3.30
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name NanoVibronix, Inc.
Country United States
Employees 10
CEO Brian M. Murphy

Stock Information

Ticker Symbol NAOV
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: NAOV

Description

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was founded in 2003 and is based in Elmsford, New York.